ES8304125A1 - "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina". - Google Patents

"un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".

Info

Publication number
ES8304125A1
ES8304125A1 ES508152A ES508152A ES8304125A1 ES 8304125 A1 ES8304125 A1 ES 8304125A1 ES 508152 A ES508152 A ES 508152A ES 508152 A ES508152 A ES 508152A ES 8304125 A1 ES8304125 A1 ES 8304125A1
Authority
ES
Spain
Prior art keywords
oxadiazolopyrimidine
intermediates
derivative
production
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES508152A
Other languages
English (en)
Other versions
ES508152A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8304125A1 publication Critical patent/ES8304125A1/es
Publication of ES508152A0 publication Critical patent/ES508152A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE OXODIAZOLOPIRIMIDINA Y DE SUS SALES, DE FORMULA (I), EN LA QUE R ES ALQUILO, ALQUENILO, ALQUINILO O ALCOXIALQUILO. CONSISTE EN LA REACCION DE 5-AMINO-7- 3,6-DIHIDRO-1(2H)-PIRIDIL -2H 1,2,4 OXADIAZOLO 2,3-C PIRIMIDIN-2-ONA CON UN DERIVADO DE AZOL DE FORMULA (II), EN LA QUE R TIENE EL MISMO SIGNIFICADO QUE EN LA FORMULA (I) Y A PUEDE SER UNO DE VARIOS RADICALES. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE INERTE A UNA TEMPERATURA COMPRENDIDA ENTRE -25 C Y LA AMBIENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE HIPERTENSIONES DE ORIGEN VASCULAR Y COMO VASODILATADORES.
ES508152A 1980-12-19 1981-12-18 "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina". Granted ES508152A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH941080 1980-12-19
CH635081 1981-10-02

Publications (2)

Publication Number Publication Date
ES8304125A1 true ES8304125A1 (es) 1983-02-16
ES508152A0 ES508152A0 (es) 1983-02-16

Family

ID=25699419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES508152A Granted ES508152A0 (es) 1980-12-19 1981-12-18 "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".

Country Status (23)

Country Link
US (2) US4410698A (es)
EP (1) EP0054866B1 (es)
KR (1) KR880001636B1 (es)
AR (1) AR229169A1 (es)
AT (1) ATE14734T1 (es)
AU (1) AU545324B2 (es)
BR (1) BR8108269A (es)
CA (1) CA1162538A (es)
CS (1) CS226738B2 (es)
DE (1) DE3171744D1 (es)
DK (1) DK148826C (es)
ES (1) ES508152A0 (es)
FI (1) FI71153C (es)
GR (1) GR76969B (es)
HU (1) HU183744B (es)
IE (1) IE51800B1 (es)
IL (1) IL64524A (es)
MC (1) MC1438A1 (es)
NO (1) NO158422C (es)
NZ (1) NZ199250A (es)
PH (1) PH17300A (es)
PT (1) PT74153B (es)
ZW (1) ZW28581A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade
CH649291A5 (de) * 1982-03-16 1985-05-15 Hoffmann La Roche Dicarbamate.
WO1986000616A1 (en) * 1984-07-13 1986-01-30 Gail Sansone Bazzano Substituted pyrimidine oxides useful for hair growth promotion
LU86959A1 (fr) * 1987-07-31 1989-03-08 Oreal Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
DE69715869T2 (de) * 1996-07-26 2003-05-28 Vantico Ag Auf epoxyharzen basierende imidazole enthaltende härtbare mischungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638215A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-derivate.
CH638216A5 (de) * 1977-02-04 1983-09-15 Hoffmann La Roche Oxadiazolopyrimidin-deriate.
CA1103245A (en) * 1978-07-21 1981-06-16 Jean-Claude Muller Process for the manufacture of novel oxadiazolopyrimidine derivatives
NZ190915A (en) * 1978-07-31 1984-07-31 Hoffmann La Roche Oxadiazolotriazine derivatives and pharmaceutical compositions
DK148826C (da) * 1980-12-19 1986-03-24 Hoffmann La Roche Analogifremgangsmaade til fremstilling af oxadiazolopyrimidinderivater eller salte deraf med baser og pyrimidinderivat til anvendelse som mellemprodukt ved denne fremgangsmaade

Also Published As

Publication number Publication date
EP0054866A2 (de) 1982-06-30
FI71153C (fi) 1986-11-24
CS226738B2 (en) 1984-04-16
US4360521A (en) 1982-11-23
FI814048L (fi) 1982-06-20
FI71153B (fi) 1986-08-14
AU7846481A (en) 1982-06-24
NZ199250A (en) 1984-04-27
CA1162538A (en) 1984-02-21
ATE14734T1 (de) 1985-08-15
IE812990L (en) 1982-06-19
IL64524A0 (en) 1982-03-31
ZW28581A1 (en) 1982-08-11
HU183744B (en) 1984-05-28
AR229169A1 (es) 1983-06-30
EP0054866B1 (de) 1985-08-07
IE51800B1 (en) 1987-04-01
BR8108269A (pt) 1982-10-05
AU545324B2 (en) 1985-07-11
NO158422C (no) 1988-09-07
PH17300A (en) 1984-07-18
DE3171744D1 (en) 1985-09-12
US4410698A (en) 1983-10-18
GR76969B (es) 1984-09-04
KR880001636B1 (ko) 1988-09-03
DK148826B (da) 1985-10-14
PT74153B (en) 1984-01-05
NO814359L (no) 1982-06-21
ES508152A0 (es) 1983-02-16
NO158422B (no) 1988-05-30
EP0054866A3 (en) 1982-09-01
MC1438A1 (fr) 1982-12-06
PT74153A (en) 1982-01-01
IL64524A (en) 1985-05-31
DK504881A (da) 1982-06-20
DK148826C (da) 1986-03-24

Similar Documents

Publication Publication Date Title
IE871733L (en) Amides
AU2234088A (en) L-dopa derivatives or their acid addition salts, process for producing same and their use
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
ES482365A1 (es) Procedimiento para la obtencion de 1-desoxi-nojirimicina.
ES8609204A1 (es) Procedimiento de preparar derivados aminicos
ES8704492A1 (es) Metodo de preparar derivados de b-carbolin-3-oxadiazolilo
IE872588L (en) Compounds
EP0132764A3 (en) New compounds derived from diphenyl-methylene-ethylamine
ES476264A1 (es) Un procedimiento para la preparacion de derivados peptidicos
ES8606337A1 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
HUT47241A (en) Process for producing alkyl-sulfonanilide derivatives and pharmaceuticals comprising them
JPS5681578A (en) Novel thioalkyl amide derivative
HUT47577A (en) Process for production of derivatives of 3h-1,2,3-triasole /4,5-d/-piramidin
ES8304125A1 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
DE3164314D1 (en) Azolylalkyl derivatives, process for their preparation and their use as fungicides
DE3854109T2 (de) Verfahren zur herstellung von chinolincarbonsäuren.
ES8204721A1 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ES8301888A1 (es) "procedimiento para la preparacion de derivados de fenoxi-aminopropanol substituidos" como divisional de la patente de invencion n 502.649 del 1 junio 1981.
ES2018403A6 (es) Procedimiento para preparar nuevas 2-carbonil sustituido-n, n' -di(trimetoxibenzoil) -piperazinas.
ES8801673A1 (es) Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida.
EP0189916A3 (en) 3-(pyrrolidinio)methyl-3-cephem derivatives, pharmaceutical composition and process for the production thereof
HUT49878A (en) Herbicide and plant growth regulator comprising heterocyclic substituted n-sultamsulfonamide derivatives as active ingredient and process for producing the active ingredients
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.